- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07473466
Evaluation of Reminder Strategies (Emails and Text Messages) to Increase Participation in the Le French Gut E-cohort
Le French Gut: Randomized-Controlled Trial to Evaluate Reminder Strategies (Emails and Text Messages) to Increase Participation in the Le French Gut E-cohort
This study is a randomized controlled trial nested in the "Le French Gut" e-cohort aiming to test the efficacy of 4 reminder strategies (emails and/or SMS with standard and/or institutional wording) in increasing participation of inactive volunteers.
This trial is led in collaboration between the "Le French Gut" project and SKEZI, a DeepTech start-up which markets the data collection solution (SKEZIA online platform) for the "Le French Gut" project and carries out the InnoPRO program, aimed at generating new knowledge in the field of e-cohorts.
Study Overview
Status
Detailed Description
The "Le French Gut" project (NCT05758961) is an ongoing online research cohort aiming to collect faecal samples and associated nutritional and clinical data to better understand the observed heterogeneity between gut microbiome of healthy subjects, its connections with the diet and lifestyle, but also changes in gut microbiota associated with diseases (diabetes, obesity, allergies, cancer, Parkinson, Alzheimer…). Le French Gut is initiated by MetaGenoPolis-INRAE, supported by INRAE with Prof. R. Benamouzig, (AP-HP) as principal investigator of the project.
When participants first register to participate in the cohort, they must complete a short "About You" ("A propos de vous") questionnaire before they can receive any study kits and be considered as active participants in the research. In October 2024, almost half of the ~43,000 individuals who have created an account never finish this first questionnaire needed to validate their participation in the cohort.
Purpose of the study This study will test which type of reminder works best for encouraging those inactive volunteers to return to the platform and complete the missing questionnaire.
How the study will be done
All eligible volunteers (i.e. people who registered on the online platform and provided a valid e mail address or mobile number but have not yet finished completing the "A propos de vous" questionnaire) will be randomly assigned to one of four groups:
- Standard e mail - a regular, semi-formal email. Same email sent three times, 72h apart.
- SMS - a short text message sent to the participant's phone. Same SMS sent three times, 72h apart.
- Institutional e mail - a plain, formal email signed by the "Le French Gut" study coordinator. Same email sent three times, 72h apart.
- Combined sequence - a standard e mail, followed 72 hours later by the SMS, and 72 hours after that by the institutional e mail.
All messages contain the same content (a link that takes the participant directly to the questionnaire). The study will last about one month after the last reminder is sent.
Questions the study will answer
- Which reminder method results in the highest completion rate of the "A propos de vous" questionnaire (i.e. proportion of people completing the questionnaire) within 30 days?
- How quickly do participants respond after each type of reminder?
- Does the time since a person first registered (recent vs. long time registrant) influence which reminder works best?
Hypothesis Investigators hypothesized that the combined sequence (standard e mail → SMS → institutional e mail) will lead to a higher proportion of participants completing the questionnaire than any single channel reminder alone.
Why this matters Finding the most effective, low cost reminder strategy will help the French Gut team-and other online cohorts-keep more participants engaged, thereby improving the quantity and quality of the data that can be used for future health research. The results will be shared in a peer reviewed scientific article and could guide the design of future e cohort studies worldwide.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Paris, France
- SKEZI
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Being registered on the "Le French Gut" platform but not active participant (e.i. eligibility questionnaire not completed, "Le French Gut" consent not validated, "A propos de vous" questionnaire not completed)
- Having provided a valid email address and/or mobile-phone number
Exclusion Criteria:
- Completed "A propos de vous" questionnaire before the first reminder
- Being non eligible to the "Le French Gut" cohort (eligibility to "Le Fench Gut" cohort: being over 18 years-old and living in France)
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: standard emails only
Standard, semi-formal worded email inviting participants to complete the online "A propos de vous" (personal information) questionnaire in order to validate their participation in the "Le French Gut" cohort.
|
The same standard email is sent three times to participants, each email spaced 72 hours apart.
|
|
Experimental: institutional emails only
Institutional, formal-worded email, signed by the study coordinator, inviting participants to complete the online "A propos de vous" (personal information) questionnaire in order to validate their participation in the "Le French Gut" cohort.
|
The same institutional email is sent three times to participants, each email spaced 72 hours apart.
|
|
Experimental: SMS only
Short text message inviting participants to complete the online "A propos de vous" (personal information) questionnaire in order to validate their participation in the "Le French Gut" cohort.
|
The same SMS (brief text message) is sent three times to participants, each SMS spaced 72 hours apart.
|
|
Experimental: Combined reminders
Combined sequence of reminders: first, the standard email; second, the SMS; third, the institutional email.
The contents of the reminders are similar to those of the three other parallel groups inviting participants to complete the online "A propos de vous" (personal information) questionnaire in order to validate their participation in the "Le French Gut" cohort.
|
Three reminders are sent to participants, each reminder spaced 72 hours apart: the first reminder is a standard email, the second reminder is a SMS, the third reminder is a institutional email.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Completion rate
Time Frame: 30 days post-reminder
|
Proportion of participants who complete the "A propos de vous" questionnaire within 30 days after the last reminder, calculated as number of participants who fully completed the questionnaire divided by total number of participants included in the study (or arm)
|
30 days post-reminder
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Completion time
Time Frame: 30 days post-reminder
|
Time (in hours) between the date the last reminder was sent to a participant and the date of questionnaire completion
|
30 days post-reminder
|
|
Login rate
Time Frame: 30 days post-reminder
|
Number of participants who logged into their account divided by total number of participants included in the study (or arm)
|
30 days post-reminder
|
|
Login time
Time Frame: 30 days post-reminder
|
Time (in hours) between the date the final reminder was sent to a participant and the date of their next login to the platform
|
30 days post-reminder
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Email opening rate
Time Frame: 30 days post-reminder
|
Number of opened emails divided by number of delivered emails
|
30 days post-reminder
|
|
Email click-through rate
Time Frame: 30 days post-reminder
|
Number of participants who clicked on the link in the email divided by number of opened emails
|
30 days post-reminder
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Jean-Philippe Bertocchio, MD, PhD, SKEZI
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- LFGxSKEZI-2024-001
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on General Population (no Specific Condition or Disease)
-
Charite University, Berlin, GermanyRecruitingGeneral Population (no Specific Condition or Disease)Germany
-
Universitat Jaume IUniversidad de Zaragoza; University of Seville; Universidad Rey Juan CarlosCompleted
-
Institut National de la Santé Et de la Recherche...RecruitingGeneral Population, no Specific ConditionFrance
-
Universidad Autonoma de Baja CaliforniaNot yet recruitingGeneral Population (no Specific Condition or Disease)
-
SKEZINot yet recruitingGeneral Population (no Specific Condition or Disease)France
-
Institut National de Recherche pour l'Agriculture...RecruitingGeneral Population (no Specific Condition or Disease)France
-
University Hospital, AngersRecruitingGeneral Population (no Specific Condition or Disease)France
-
Ruhr University of BochumCompletedMental Health | Randomized Controlled Study | Positive Emotions | General Population (no Specific Condition or Disease) | Intervention (Training) ConditionGermany
-
University of PadovaCompletedHoarding Disorder | Virtual Reality Based Therapy | General Population (no Specific Condition or Disease)Italy
-
NYU Langone HealthNew York City Health and Hospitals CorporationCompleted
Clinical Trials on 3 standard email reminders
-
Institute for Clinical Evaluative SciencesCanadian Institutes of Health Research (CIHR); Ontario Agency for Health Protection... and other collaboratorsCompletedAntibiotic Initiation | Antibiotic DurationCanada
-
University of PennsylvaniaHarvard University; Donaghue Medical Research Foundation; National Bureau of...Completed
-
Rush University Medical CenterAmerican Orthopaedic Society for Sports MedicineActive, not recruiting
-
Mahsa UniversityCompleted
-
University of California, Los AngelesCompletedDiabetes | Cervical Cancer Screening | Primary Health Care | Behavioral Economics | Colorectal Cancer Screening | Health Maintenance | Chlamydia Screening | HPV ScreeningUnited States
-
University of California, Los AngelesRecruitingPrimary Health Care | Behavioral Economics | Health MaintenanceUnited States
-
University of MichiganNational Library of Medicine (NLM)Active, not recruiting
-
Addis Ababa UniversityRecruitingSuspicious Cervical Cancer Lesions Follow up AdherenceEthiopia
-
Geisinger ClinicCompleted
-
European Institute of OncologyRecruiting